JPH203 (Nanvuranlat) LAT1 Inhibition Augments Rapamycin-Insensitive mTOR Protein Synthesis

Dorsomorphin Dihydrochloride Dorsomorphin AMPK Inhibition Modulates Neuroinflammatory Cascades

10058-F4 inhibitor suppresses c-MYC/SLC7A5 signaling to block hBMSC osteogenic differentiation

TEPP-46 (ML265) PKM activator selectively promotes PKM2 tetramerization to prevent aortic aneurysm formation

Dimethyloxallyl Glycine (DMOG) Targets PHD to Mitigate Hepatic Ischemia-Reperfusion Injury via HIF-1α Activation

SRI-011381 (C381) SRI-011381 TGF-beta/Smad Agonism Suppresses PEMF Antifibrotic Efficacy

SN-38 from Selleck targets Topoisomerase I to induce double-stranded DNA damage in glioma

Ceralasertib (AZD6738) Suppresses ATR Kinase in High-Risk Relapsed Chronic Lymphocytic Leukemia

Cyclosporin A from Selleck Suppresses Calcineurin NFAT Signaling in T-Cells

SC79 Enforced AKT Phosphorylation Mitigates Matrine Induced Glioblastoma Senescence

AZD5363 (Capivasertib) Formulations Display Pharmacokinetic Bioequivalence in Advanced Solid Tumors

G418 Sulfate (Geneticin) Target Engagement at Escherichia coli DNA Ligase OB-Fold Site 1

Actinomycin D (Dactinomycin) Inhibits DNA and RNA Polymerase in Gestational Trophoblastic Neoplasia

Oligomycin A from Selleck and Oligomycin A (MCH 32) Direct Mitochondrial ATP Synthase Inhibition

Q-VD-Oph inhibitor suppresses caspase activation shifting ischemic death toward necroptosis

Mitomycin C Blunts Subconjunctival Fibroblast Proliferation to Preserve Microshunt Bleb Patency

Emricasan Caspase inhibitor IDN-6556 dual engagement of ACE2 and caspase-3 in viral pathology

Navitoclax (ABT-263) Inhibits Bcl-2 and Triggers Beclin-1 Autophagy to Restore Macrophage Function

2-DG (2-Deoxy-D-glucose) 2-DG Carbohydrate Metabol modulator Targets Glycolysis in COVID-19 Clinical Trial

ABT-199 (Venetoclax) ABT199 Selective BCL2 Inhibition in B-Cell Malignancies

MK-2206 Dihydrochloride (MK-2206) suppresses AKT signaling and alters metabolic profiles in solid tumors

Staurosporine (STS) Staurosporine Model Evaluation for Pediatric Cardiac Surgery Mortality Risk

Forskolin (Colforsin) from Selleck Activates Adenylate Cyclase to Attenuate Vascular Restenosis

Z-VAD-FMK Caspase inhibitor attenuates smoke-induced airway inflammation and emphysematous tissue destruction

Ezetimibe (SCH-58235) and Ezetimibe from Selleck Target NPC1L1 for Post-ACS Lipid Lowering

FB23-2 Target Engagement of FTO Inhibits m6A Demethylation in Hypoxic Hepatocytes

Trimetazidine dihydrochloride FAO inhibitor targets 3-KAT to shift metabolism and reduce cancer risk

GS-4997 ASK inhibitor suppresses hepatic stellate cell activation and exosomal signaling in fibrosis

TH5487 Inhibits OGG1 to Activate PINK1 Parkin Mitophagy in Pulmonary Fibrosis

Olitigaltin (TD139) Olitigaltin from Selleck Galectin-3 Inhibitor in Peritoneal Carcinomatosis

Tomivosertib (eFT508) Inhibits MNK1/2 to Suppress eIF4E Phosphorylation and Immune Evasion

Asunaprevir from Selleck targeted HCV NS3 protease inhibition for hepatitis C treatment

WZB117 Inhibition of Class I Glucose Transporters Suppresses Glycolytic Metabolism in Oncology Models

DSS Crosslinker Mediated Nanosphere Conjugation Reduces CD11b Antibody Binding Affinity

Idasanutlin (RG7388) Potentiates p53 Signaling and Apoptosis in Cutaneous Melanoma Models

Pentylenetetrazol GABA Receptor Antagonist Mechanisms in Zebrafish Seizure Models

CADD522 from Selleck suppresses RUNX2-mediated ITGBL1 activation to attenuate HBV-induced liver fibrosis

GSK1349572 Integrase inhibitor (Dolutegravir) mechanisms against HIV-1 strand transfer resistance

BMS-202 BMS202 PD-1 PD-L1 Checkpoint Inhibitor Hydrogel Loading and Release

PF-04418948 antagonist suppresses EP2 and EP4 receptor-mediated airway microvascular leakage

Caerulein (Cerulein, FI-6934) from Selleck Induces CCK Receptor-Mediated Pancreatic Microvascular Hyperemia

NMS-873 p97 allosteric inhibition attenuates cellular tau seed processing and aggregation

AS1842856 from Selleck Inhibits FoxO1 Transactivation to Suppress Cardiac Fibroblast COX-2 Expression

BX-795 PDPK1 Inhibition Suppresses Allergic Airway Inflammation via Th-IL-2 Cell Lineage Induction

Sulfosuccinimidyl Oleate Sodium from Selleck models Stressor–Strain–Outcome dynamics in digital cyberchondria

CA-074 methyl ester (CA-074 Me) inhibits cathepsin B in hypoxic glioma cells

CD38 inhibitor 1 CD markers targeting PD-1 PD-L1 immune checkpoint inhibition in multiple myeloma

ASP2215 (Gilteritinib) ASP2215 FLT3 inhibitor targeting secondary mutations and microenvironmental resistance in leukemia

XMU-MP-1 (XMUMP1) Inhibition of MST1/2 Reverses Hippo-Mediated Protection in Intestinal Sepsis Models

Valemetostat (DS-3201) targeting EZH1/2 histone methyltransferases enables disease control in aggressive T-cell lymphoma

UK-5099 (PF-1005023) Mitochondrial pyruva inhibitor Targets Subtype-Specific OXPHOS in Pancreatic Cancer

SB-525334 and SB525334 inhibit TGF-beta1 SMAD4 signaling during mild ablation

LB-100 LB100 PP2A inhibitor Sensitizes Tumors via DNA Repair Suppression

Ac-CoA Synthase Inhibitor1 (ACSS2 inhibitor) Ac-CoA ACSS2 suppresses raptor/mTORC1 in diabetic nephropathy

MCC950 from Selleck Inhibits NLRP3 Inflammasome NACHT Domain in Colitis Models

Necrosulfonamide targets GSDMD-N to inhibit dendritic cell pyroptosis in allergic rhinitis

IACS-010759 (IACS-10759) and IACS-10759 from Selleck Target Complex I in Resistant Melanoma

Denifanstat (TVB-2640) targets FASN to disrupt de novo palmitate synthesis in endocrine-resistant breast cancer

Atglistatin Lipase inhibitor PNPLA2 Suppression Selectively Uncouples Macrophage Differentiation From Tumor Phagocytosis

BMS-927711 (Rimegepant) BMS-927711 CGRP receptor blockade attenuates migraine frequency

Finerenone (BAY 94-8862) Nonsteroidal Mineralocorticoid Receptor Antagonism in Renal Disease

LY2109761 Inhibition of TβRI/II Suppresses TGFβ1/Smad-Mediated Stem Cell Transdifferentiation

SB505124 Targeting of TGF-β Receptor Reverses High-Risk Programmed Cell Death Phenotypes in KIRC

PDD00017273 targets PARG to sensitize colorectal cancer cells to standard chemotherapy regimens.

EN6 Lipopeptide Biosurfactant Enhances Electrokinetic Remediation of Soil Chromium Contamination

Importazole from Selleck Inhibits KPNB1 Nucleocytoplasmic Transport and Prostate Cancer Growth

Thiamet G Selective Glycosidase Inhibition Profile Against Beta-N-Acetylglucosaminidase Enzymes

Epacadostat (INCB024360) IDO1 Inhibition in First-Line Metastatic Renal Cell Carcinoma Phase 3 Trial

Talabostat inhibitor Talabostat (Val-boroPro, PT-100) Mesylate targets DPP4 DPP8 DPP9 FAP

NMDA (N-Methyl-D-aspartic acid) NMethylDaspartic NMDAR Excitotoxicity in Alzheimer Disease

Relacorilant from Selleck (CORT125134) selectively antagonizes glucocorticoid receptors in hypercortisolism disorders

Ko143 BCRP inhibitor Blocks ABCG2 Efflux at Blood-Placenta Barrier

Gsk484 Hydrochloride (Gsk484) Inhibits PADI4 to Reverse Lenvatinib Resistance in Hepatocellular Carcinoma

Setmelanotide (RM-493) and Setmelanotide from Selleck Target MC4R in Rare Genetic Obesity

Vorapaxar (MK-5348) Reversibly Inhibits Protease-Activated Receptor-1 Signaling in Atherothrombosis

SF1670 Regulates PTEN AKT Signaling to Modulate Non-Small Cell Lung Cancer Invasion

Crenigacestat (LY3039478) Suppresses GINS1-Driven Notch/PI3K/AKT/mTORC1 Signaling in LUAD

Compstatin from Selleck inhibits C3 cleavage to block C3b dependent platelet aggregation

MK571 MK-571 (L-660711) Mediates ABCC5 Efflux Transporter Inhibition in Hepatocellular Carcinoma

Monastrol Inhibition of Kinesin Eg5 Induces Monopolar Spindle Arrest in Cancer Cells

Tat-beclin 1 Beclin activator Restores Autophagic Flux in Klebsiella pneumoniae Sepsis

PKR-IN-C16 PKRINC16 PKR inhibitor targets SPT1 in de novo ceramide synthesis

Firsocostat inhibitor Firsocostat (GS-0976, ND-630) Targets ACC1 in Renal Fibrosis

Auranofin (SKF-39162) Auranofin Bacterial inhibitor Targets Thioredoxin Reductase in Toxoplasma

Tiplaxtinin (PAI-039) from Selleck Targets PAI-1 to Attenuate Microvascular Thrombosis Post-TBI

Dooku1 Selective Antagonism of Yoda1-Induced Piezo1 Mechanosensitive Ion Channel Activation

NNMTi Targeted Inhibition Depletes 1-MNA and Restores Epigenetic Methylation in Solid Tumors

BMS-303141 inhibitor targets ATP citrate lyase to suppress hepatic alanine transamination and gluconeogenesis

BMS-309403 Inhibition of FABP4 Mitigates Ischemia-Reperfusion Injury in Steatotic Livers

WRW4 antagonist suppression of FPR2 blocks peripheral inflammatory pain resolution

ABR-215757 from Selleck Blockade of S100A9 Restores Cardiac Mitochondrial Homeostasis

MitoPQ from Selleck Targets Mitochondrial Complex I to Generate Selective Superoxide